Preoperative Treatment of Locally Advanced Rectal Cancer
Deborah Schrag(Dana-Farber Brigham Cancer Center), Harvey J. Mamon(Brigham and Women's Hospital), Thomas J. George(University of Florida Health), Garth D. Nelson(Mayo Clinic), Joel E. Goldberg(Brigham and Women's Hospital), Jeffrey A. Meyerhardt(CancerCare), Leonard B. Saltz(Memorial Sloan Kettering Cancer Center), Alan P. Venook(University of California, San Francisco), Michael Montemurro(University Hospital of Lausanne), Qian Shi(Mayo Clinic), George J. Chang(The University of Texas MD Anderson Cancer Center), Benjamin Musher(Baylor College of Medicine), Karyn A. Goodman(Icahn School of Medicine at Mount Sinai), Tareq Al Baghdadi(IHA Hematology Oncology Consultants), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Ardaman Shergill(University of Chicago), Jeffrey M. Farma(Fox Chase Cancer Center), Amylou C. Dueck(Mayo Clinic in Arizona), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Brian Colgrove(Mayo Clinic), Hagen F. Kennecke(Virginia Mason Medical Center), Robert R. McWilliams(Mayo Clinic in Arizona), Vallerie Gordon(Memorial Sloan Kettering Cancer Center), Martin R. Weiser(Memorial Sloan Kettering Cancer Center)
Cited by 440
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k